Browse by Audience
Skip to content
Papers of the Week
Low-dose ketamine infusions reduce opioid use in pediatric and young adult oncology patients.
Authors
Abstract
Ketamine is an NMDA-receptor antagonist with analgesic and opioid-sparing properties. Although well studied in adults, more robust evidence supporting ketamine's use for pediatric pain management is needed. This retrospective study evaluates ketamine's opioid-sparing effectiveness in pediatric and young adult oncology and hematology patients.